Seeking Alpha

BD Onclarity™ HPV Assay Receives FDA Approval for Use with Both BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap Test

FRANKLIN LAKES, N.J., Feb. 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) ...
Labroots

Finally, an HPV test cleared for use with SurePath

It may seem like just yesterday, OK it was around 1997, when an HPV (human papillomavirus) test was approved for use by the FDA with a specific media— ThinPrep—as an important triage test for women ...
Business Insider

BD Submits Pre-Market Approval Supplement to FDA to Enable ThinPrep® Pap Test™ PreservCyt® Solution to be Used with the BD Onclarity™ HPV Assay

FRANKLIN LAKES, N.J., Sept. 23, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has submitted a pre-market ...
Cure Today

FDA Approves Test to Identify Women with Increased Risk for Cervical Cancer

This HPV-based test can help identify women who are at an increased risk for cervical cancer. BD Onclarity HPV Assay, a test that can detect up to 14 types of high-risk human papillomavirus (HPV) and ...
Cure Today

HPV Test Used With SurePath Preservative Fluid Gains FDA Approval

Roche cobas HPV Test gained U.S. Food and Drug Administration (FDA) approval for the use with SurePath Preservative Fluid to detect human papilloma virus (HPV) in cervical cells. SurePath is one of ...
The Trentonian

BD Announces Industry-First CE Marked Assay for HPV Screening from At-Home Self-Collected Vaginal Samples

FRANKLIN LAKES, N.J., May 13, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the industry’s first self-collection ...